Background: Nephrolithiasis has been associated with hypertension, obesity and
Introduction
Nephrolithiasis is a relatively prevalent disease in Western civilizations 1 .
Epidemiological studies documented an association of nephrolithiasis with obesity, diabetes Mellitus and arterial hypertension [2] [3] [4] [5] . These comorbidities are manifestations of the metabolic syndrome and their high prevalence in KSF points to an involvement of insulin resistance in the pathophysiology of nephrolithiasis 6;7 . Obesity and diabetes promote lithogenesis: uric acid stones are more common in diabetic patients 8 and obesity increases the urinary excretion of promoters of crystallization, urine acidity, and contributes to an increase of calcium oxalate lithogenesis 9;10 . An increased risk of kidney stone formation was documented in obese individuals in a large prospective study 11 and in individuals with a high fructose consumption 12 , a natural sugar implicated in the development of the metabolic syndrome in humans 13 .
There is some evidence of an increase of the risk factors for coronary heart disease in KSF 14 The existence of each chronic disease was coded in a dummy variable, according to the following criteria: a positive answer of the respondents on whether they have or had ever had the disease mentioned, plus a positive response whether that knowledge was transmitted to them by a physician or nurse. The age of onset of the disease and/or diagnosis, and the use of drugs or any other form of treatment were also asked.
Anthropometric data collected at the time of questionnaires included weight and height. Obesity was defined as body mass index (BMI) ≥ 30 Kg/m 2 .
Sample selection
The sample used in the 4 th NHS was randomly selected from a mother-sample used by the NIS for studies with families among residents in private households from a representative sample of households from the mainland and the autonomous regions of Azores and Madeira, using a system of stratification and systematic selection. The 
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The areas of the interview were selected approximately equally by quarter and week, to minimize possible seasonal effects of the survey results.
We used the questionnaires of all respondents aged ≥ 15 years-old and whose answers were provided directly to the interviewers; proxy answers were excluded.
Statistical methods
A descriptive statistics for all variables was carried out. Categorical variables were The prevalence of hypertension, obesity, diabetes, stroke, and myocardial infarction was significantly higher in KSF than in the general population (Table 1) .
After correction for age, the odds-ratio (O.R.) for obesity was 29% higher in the population with nephrolithiasis compared with non-stone formers (O. 67 of them were diabetic and 422 were not (P = NS).
After adjustment for age and BMI, the probability of myocardial infarction (O.R. Figure 2 ).
Discussion
This study identified significant associations between nephrolithiasis and hypertension, diabetes, myocardial infarction and stroke. Previous studies have documented an increased prevalence and incidence of hypertension in stone formers 18;19 and a higher incidence of nephrolithiasis in hypertensive patients 20;21 . To our knowledge, only one study published in 1973 documented an increased prevalence of coronary heart disease in KSF 22 , and that result was not confirmed by others 23 . Our study provides the first independent confirmation of an association between nephrolithiasis and coronary heart disease in a large-scale population, and also confirms an increased prevalence of stroke in KSF.
In this study, the associations between nephrolithiasis and hypertension, diabetes or CVD were only partly justified by the older age and higher BMI of KSF. The relations of hypertension with age and BMI are well documented in older age groups 24 and obese individuals 25 . However, the O.R. for hypertension in our population with nephrolithiasis remained higher after adjusting the results for age and BMI, suggesting the existence of further risk factors.
Obesity is a known risk factor for diabetes and cardiovascular diseases 26 , but in our study the association of nephrolithiasis with diabetes remains significant after adjustment for age and BMI. It is conceivable that the adverse effects of certain forms of treatment of kidney stone disease may result in an increased risk of diabetes and CVD. Thiazide diuretics are frequently used in the treatment of nephrolithiasis, and a possible association between low-dose thiazide diuretics an enhanced risk of diabetes was recently reported by Taylor et al. 27 . An increased risk of diabetes has also been documented in patients undergoing extracorporeal shock wave lithotripsy 28 .
However, only a minor proportion of patients in our population had been submitted to any form of treatment for nephrolithiasis, except for symptomatic treatment, and in 8 those who were treated no association was observed between treatment and the development of diabetes or CVD.
In our study, the age of the diagnosis of nephrolithiasis proceeded the age of the diagnosis of diabetes and other cardiovascular outcomes, in most cases by several years. Even considering that the onset of type 2 diabetes may precede its clinical diagnosis by as much as seven years 29 , kidney stone disease cannot be interpreted as a consequence of diabetes, as usually described in medical literature, but, instead, it appears to occur early in life in individuals with a greater predisposition for the future development of diabetes.
In the past, the search for an association between nephrolithiasis and coronary heart disease gave contradictory results 22;23;30 . Our results document an association between nephrolithiasis and myocardial infarction later in life and, in women, nephrolitiasis remains an independent risk factor after adjustment for the presence of diabetes and hypertension.
Li et al. 31 found a high percentage of cases with a history of kidney stones in patients with normal blood pressure who developed stroke over 6-year follow-up, but that difference did not reach statistical significance after adjustment for other risk factors .
Our study confirms the association between nephrolithiasis and stroke and explains it by the higher prevalence of hypertension and diabetes observed in KSF.
Nephrolithiasis is gradually being recognized as a systemic disease indicative of an adverse metabolic environment 32;33 . The differences in the ages of diagnosis of the different co-morbidities found in our study suggests that the causal mechanism may already be present when the lithogenic process began, and its identification should be part of a more comprehensive intervention in kidney stone prevention.
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The results express the need for prospective long-term studies to access the risk for CVD and diabetes in kidney stone disease and it is recommended to undertake a careful assessment of cardiovascular risk factors in stone forming patients.
Limitations:
The recognition of comorbidities was based on the knowledge that patients have about their own health status and we admit some bias related to the fact that individuals affected by one disease condition may have a greater probability of other conditions 
